Please login to the form below

Not currently logged in
Email:
Password:

Merck Foundation

This page shows the latest Merck Foundation news and features for those working in and with pharma, biotech and healthcare.

Merck's new health charity strikes partnership deal with Tanzania

Merck's new health charity strikes partnership deal with Tanzania

The Merck Foundation will provide one and two year surgical and paediatric oncology fellowship programme in India, Europe and the University of Nairobi for Tanzanian doctors to improve the cancer care ... Rasha Kelej, chief executive officer of Merck

Latest news

  • Merck launches HCV awareness campaign

    In addition, Merck is sponsoring the expansion of the American Liver Foundation's Treatment Choices Initiative, which includes community-based education programmes centered around perspectives from healthcare providers and from individuals

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • New Merck Foundation appoints Rasha Kelej New Merck Foundation appoints Rasha Kelej

    Rasha Kelej has been appointed chief executive officer for Merck KGaA’s non-profit limited liability company, The Merck Foundation. ... She said: “The Merck Foundation will focus on initiatives that will contribute towards the Sustainable Development

  • Merck names head of strategic communications Merck names head of strategic communications

    Merck has named Dr Julie Gerberding as executive vice president for strategic communications, global public policy and population health. ... In the newly created position within the executive committee, Gerberding will be responsible for Merck's global

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...